✦ LIBER ✦

First line chemotherapy with paclitaxel (P) and mitoxantrone (M) metastatic breast cancer (MBC). A phase II study

✍ Scribed by Tsavdaridis, D.; Athanassiadis, A.; Kourtidou, P.; Hatzikonstantinou, N.; Saleh, M.; Hatzichristou, A.; Karapanagiotis, K.; Moschidis, A.; Liaros, A.; Apostolidis, A.; Harmouziadis, G.

Book ID: 122667813
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 315 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81723-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with paclitaxel

Combination chemotherapy with paclitaxel (T) and epirubicin (E) for metastatic breast cancer (MBC): A phase I–II study

✍ A. Durando; O. Alabiso; R. Bellino; F. Genta; D. Katsaros; A. Malossi; S. Aidala 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 324 KB

PP-7-5 phase II study of paclitaxel (P)

PP-7-5 phase II study of paclitaxel (P) and eplrubicin (E) as first-line therapy in patients (PTS) with metastatic breast cancer (MBC)

✍ Ch. Thomssen; H.-J. Lück; A. du Bois; B. Lisboa; M. Untch; G. Köhler; D. Hecker; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Weekly paclitaxel as first-line chemothe

Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial

✍ A.J ten Tije; C.H Smorenburg; C Seynaeve; A Sparreboom; K.L.C Schothorst; L.G.M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Mitomycin (M), epirubicin (E) and vinore

Mitomycin (M), epirubicin (E) and vinorelbine (V) first-line chemotherapy for metastatic breast cancer (MBC). A feasibility study

✍ Alessandro Neri; Alfredo Guarnieri; Enrico Tucci; Fiorella Pepi; Bruno Mazzocchi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase II study in patients (PTS) with me

Phase II study in patients (PTS) with metastatic breast cancer (MBC)

✍ Giocomi, N.; Pascual, M.; García, J.; Stagnaro, A.; Chirino, M.; Algamiz, C.; Es 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A phase II study of paclitaxel plus carb

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi